Winton Group LTD Ptc Therapeutics, Inc. Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $228,987 - $334,978	5,668 New	5,668 $230,000
Q1 2020 May 11, 2020	SELL	$32.37 - $59.36 $370,701 - $679,790	-11,452 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $368,983 - $573,401	11,452 New	11,452 $550,000
Q2 2019 Jul 08, 2019	SELL	$35.42 - $45.0 $254,917 - $323,865	-7,197 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$28.09 - $39.49 $44,017 - $61,880	-1,567 Reduced 17.88%	7,197 $271,000
Q4 2018 Feb 05, 2019	BUY	$29.83 - $46.51 $85,701 - $133,623	2,873 Added 48.77%	8,764 $301,000
Q3 2018 Nov 02, 2018	BUY	$33.9 - $47.77 $199,704 - $281,413	5,891 New	5,891 $0

232

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.